Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00942032 · ClinicalTrials.gov registry record
Clinical Experience With the Hindfoot Arthrodesis Nail for the Surgical Treatment of Ankle and Hindfoot Pathologies
A clinical trial, sponsored by AO Clinical Investigation and Publishing Documentation.
- Completed
- Registry status
- 39
- Enrollment target
NCT00942032: Completed study, sponsored by AO Clinical Investigation and Publishing Documentation.
NCT00942032 is a clinical trial that has completed, run by AO Clinical Investigation and Publishing Documentation. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00942032 has completed, sponsored by AO Clinical Investigation and Publishing Documentation.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
The aim of this observational study is to collect and evaluate the current clinical experience gained from the Hindfoot Arthrodesis Nail (HAN) for ankle and hindfoot fusions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-04 |
What the finished NCT00942032 record still lists
NCT00942032 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00942032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00942032 about?
NCT00942032 is a clinical study titled "Clinical Experience With the Hindfoot Arthrodesis Nail for the Surgical Treatment of Ankle and Hindfoot Pathologies". The aim of this observational study is to collect and evaluate the current clinical experience gained from the Hindfoot Arthrodesis Nail (HAN) for ankle and hindfoot fusions.
What is the current status of trial NCT00942032?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2009-05. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT00942032?
This trial is sponsored by AO Clinical Investigation and Publishing Documentation, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia